Evaluating telemedicine for administering safe medical abortions
A new study is the first to evaluate how telemedicine can help vulnerable women access safe medical abortions.
The World Health Organization (WHO) states that...
Can Artificial Intelligence reduce drug side effects?
Research led by the University of Exeter could mean that clinicians can assess drug side effects using Artificial Intelligence (AI).
The University of Exeter with...
New Marfan syndrome treatment could delay the need for surgery
A new Marfan syndrome treatment could delay the need for surgery and reduce aortic root size in patients, according to research presented at the...
Using engineered yeast cells to create an anti-cancer drug
A new study by the Technical University of Denmark utilised reprogramed yeast to produce vinblastine, an essential anti-cancer drug.
In 2019, some cancer patients experienced...
New approach to treating leukaemia in children may reduce side effects
By using drugs currently used to treat other diseases, scientists hope they can reduce the side effects of medication used to treat leukaemia in...
Scientists discover a novel method to extend the shelf life of vaccines
New research illuminates the necessity of extending the shelf life of vaccines and finds a new approach to mitigate common vaccine problems.
It is reported...
Using ultra-low freezers to maintain the viability of cell and gene therapy products
B Medical Systems explain how their ultra-low freezers can offer valuable cold chain solutions for the burgeoning cell and gene therapy market.
Many cell and...
New drug could revolutionise rheumatoid arthritis treatment
A new drug for treating rheumatoid arthritis has shown to be highly effective and could offer patients new hope.
Rheumatoid arthritis is a long-term condition...
Gene therapy for achromatopsia in children partly restores cone function
A new study by University College London has found gene therapy for achromatopsia in children partly restored cone function.
Achromatopsia is a rare inherited condition...
UCL researchers’ trial anti-sickness drug for dementia hallucinations
Ondansetron, an anti-sickness drug used in the NHS for cancer patients could treat hallucinations in dementia patients.
University College London is trialling an anti-sickness drug...
New anti-cancer drug in development
Researchers in the US have been working on a new anti-cancer drug. The drug will be absorbed through the gut’s lymphatic system, allowing new...
New mRNA cancer vaccine eliminates tumours
A new mRNA-based cancer vaccine shows potential in eliminating tumours and preventing recurrence in mice.
Cancer vaccines are a controversial topic with plenty of research...
New method reduces pain after knee replacement surgery
A new study finds that infusing morphine into shin bone could reduce pain after knee replacement surgery.
A recent study by Houston Methodist researchers found...
Prostate drug could revolutionise motor neuron disease treatment
A new study has found a repurposed drug could help patients with their motor neuron disease treatment.
University of Edinburgh researchers have found a drug...
Predicting effective drug combinations for postmenopausal osteoporosis
A new mathematical model could help clinicians choose effective combinations of medications for postmenopausal osteoporosis.
Postmenopausal osteoporosis occurs when the sudden loss of oestrogen during...
Azenta announces acquisition of B Medical Systems
Azenta Inc. has announced its agreement to acquire B Medical Systems, a market leader in temperature-controlled storage and transportation solutions.
In an exciting development, Azenta...
Defence Therapeutics receives US patent for its ADC Platform Technology
In an exciting development, Defence Therapeutics has received a US patent covering its ADC Platform Technology.
In the latest announcement on August 8th, 2022, Defence...
Lung cancer treatment stops cancer worsening for over two years
A life-extending lung cancer treatment is available on the NHS, which could benefit over 550 patients a year.
The revolutionary lung cancer treatment is called...
WHO recommends cabotegravir for HIV prevention
New WHO guidelines recommend countries implement cabotegravir into their HIV prevention strategy.
The World Health Organization (WHO) has released new guidelines for cabotegravir (CAB-LA) and...
NHS saves £1.2 billion of taxpayer money on cutting-edge medications
In a new press release, the NHS has stated they have saved £1.2bn on life-changing medications by securing cost-effective deals.
The NHS has announced that...
